Teva is a global generic pharmaceuticals leader and one of the top 15 pharmaceutical companies in the world. Headquartered in Israel, Teva operates in 60 countries and has 45,000 employees worldwide.
Established in 1901, Teva takes great pride in its long tradition of leadership and dedication to excellence.

Teva specializes in development, production and marketing of a wide range of generic and branded products, as well as active pharmaceutical ingredients (API).

For over a century, Teva has maintained a distinct competitive edge through:

  • High quality offerings
  • Focus on customers and patients
  • Balanced product portfolio (both generic and innovative)
  • Integration of pharmaceutical and API activities
  • Combination of global operations with local customer responsiveness
  • Established international presence through a tailored network of worldwide subsidiaries

Teva began its operation in North Carolina on November 1, 2011, when it became the owner of Proctor & Gamble’s South Swing Road plant in Greensboro.  This is the beginning of a joint venture between Teva and P & G, designed to give Teva a stronger hold in North American Manufacturing, while opening up international markets to P & G’s lines of personal healthcare items.  At the South Swing Road plant, Teva will continue the manufacture of Pepto-Bismal, Vicks products, Nyquil, Dayquil, as well as other P & G products.

5 Basel St. 100 S. Swing Rd.
Petach Tikva, Israel 49131 Greensboro, NC USA 27409
Phone: + 972-3-914-8292 Phone: + 1-336-954-0000
Fax: +1-336-954-4262
adva.erlich@teva.co.il darren.alkins@tevausa.com